Try our Advanced Search for more refined results
May 13, 2022
Horizon Medicines LLC et al v. Apotex Inc. et al
Case Number:
1:22-cv-00640
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 08, 2022
Apotex Dodges Horizon Patent Suit Over Generic Pennsaid
A Delaware federal judge has cleared pharmaceutical maker Apotex in rival Horizon's patent suit over a generic version of anti-inflammatory drug Pennsaid, ruling that Apotex's agreement with a different licensor grants the generic maker implied rights to the continuation patent at issue.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login